BHST vs OBIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OBIO Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) driven by superior Momentum & Technical, Options & Structure while BHST counters with relative strength in Growth & Margin. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus OBIO at N/M Forward P/E and -195.4% operating margin (-89.4% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OBIO sits in CONSOLIDATION (21st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BHST Revenue | OBIO Revenue | BHST Op. Margin | OBIO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2022 | N/A | $0M | N/A | -924.3% | OBIO |
| FY2023 | $10M | $0M | -78.6% | -1866.2% | BHST |
| FY2024 | $30M | $0M | -27.7% | -2437.5% | BHST |
| FY2025 | $30M | $30M | -16.2% | -154.7% | BHST |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BHST | OBIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9M | $550.9M | Larger Scale | OBIO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +3.8% | -89.4% | Higher Growth | BHST |
| Operating Margin (TTM) Profitability | -18.0% | -195.4% | Higher Margin | BHST |
| Net Profit Margin Profitability | -31.2% | -182.5% | Higher Margin | BHST |
| Return on Equity (ROE) Capital Efficiency | -142.5% | -182.3% | Higher ROE | BHST |
| 52-Week Range Position Momentum | 6% ($1โ$7) | 72% ($3โ$8) | Stronger Trend | OBIO |
| Beta / 30D Volatility Risk Regime | 0.25ฮฒ ยท 86% Vol | 1.18ฮฒ ยท 88% Vol | Lower Realized Risk | BHST |
| Unified Institutional Score Composite Signal | 58.2 / 100 (HOLD) | 41.1 / 100 (SELL) | Higher Composite | BHST |